Insider Transactions in Q1 2025 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-1.23%
|
-
|
|
Feb 14
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,667
+4.82%
|
-
|
|
Feb 14
2025
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+0.54%
|
-
|
|
Feb 14
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,965
-11.7%
|
-
|
|
Feb 14
2025
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+24.64%
|
-
|
|
Feb 14
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,125
-9.32%
|
-
|
|
Feb 14
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,667
+24.13%
|
-
|
|
Feb 14
2025
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,435
-3.41%
|
-
|
|
Feb 14
2025
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.3%
|
-
|
|
Feb 14
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+37.22%
|
-
|
|
Feb 14
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,667
+1.42%
|
-
|
|
Feb 14
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+0.8%
|
-
|
|
Feb 14
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.11%
|
-
|
|
Feb 14
2025
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,574
-0.58%
|
-
|
|
Feb 14
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.45%
|
-
|
|
Jan 08
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+9.24%
|
$100,000
$2.24 P/Share
|
|
Jan 02
2025
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,600
-3.81%
|
-
|
|
Jan 02
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,105
+13.16%
|
-
|
|
Jan 02
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,941
-41.2%
|
-
|
|
Jan 02
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,138
+50.0%
|
-
|